NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NovaDigm Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7588
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal and bacterial pathogens vaccines, and vaginal and bloodstream infections treatment vaccines. It also provides RWC treatment vaccines, skin and soft tissue infection treatment vaccines, vulvovaginal candidiasis vaccines, endothelial cells, nosocomial infection vaccines, venous catheters, and feeding tubes, among others. NovaDigm offers services such as preclinical studies, candidates development, clinical trials, clinical discoveries, and invasive medical devices development services. The company’s products are used in treatment of mucosal, skin, and life-threatening systemic infections. NovaDigm is headquartered in Brookline, Massachusetts, the US.

NovaDigm Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 10
NovaDigm Therapeutics Acquires Rights to Secreted Aspartyl Proteinase 2 from Pevion Biotech and Italian National Health Institute 11
Venture Financing 12
NovaDigm Therapeutics Raises US$14 Million In Series B Financing 12
NovaDigm Therapeutics Raises US$10 Million In Extended Series A Financing 13
Licensing Agreements 14
NovaDigm Therapeutics Enters into Licensing Agreement with Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 14
NovaDigm Therapeutics Inc – Key Competitors 15
NovaDigm Therapeutics Inc – Key Employees 16
NovaDigm Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Sep 25, 2018: U.S. Challenges World to Intensify Global Fight against Antibiotic Resistance 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovaDigm Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 10
NovaDigm Therapeutics Acquires Rights to Secreted Aspartyl Proteinase 2 from Pevion Biotech and Italian National Health Institute 11
NovaDigm Therapeutics Raises US$14 Million In Series B Financing 12
NovaDigm Therapeutics Raises US$10 Million In Extended Series A Financing 13
NovaDigm Therapeutics Enters into Licensing Agreement with Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center 14
NovaDigm Therapeutics Inc, Key Competitors 15
NovaDigm Therapeutics Inc, Key Employees 16

List of Figures
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovaDigm Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MAN SE (MAN)-エネルギー分野:企業M&A・提携分析
    Summary MAN SE (MAN) is a commercial vehicle and mechanical engineering company. It involves in designing, developing, manufacture and sale of wide range of engineering goods such as trucks, buses, diesel engines, turbo machinery, and special gear systems. The company operates production facilities …
  • State Oil Company of the Azerbaijan Republic:石油・ガス:M&Aディール及び事業提携情報
    Summary State Oil Company of the Azerbaijan Republic (SOCAR) is an oil and gas exploration company. The company explores oil and gas fields; and produces, processes and transports oil, gas and gas condensate. It markets petroleum and petrochemical products in domestic and international markets and s …
  • Targa Resources Partners LP (NGLS PR A):企業の財務・戦略的SWOT分析
    Targa Resources Partners LP (NGLS PR A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Icagen Inc:企業のM&A・事業提携・投資動向
    Icagen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icagen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cell Signaling Technology Inc-医療機器分野:企業M&A・提携分析
    Summary Cell Signaling Technology Inc (CST) is a biotechnology company that develops and manufactures antibody products for medical research and clinical diagnostic market. The company products include primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, ELISA Kits, anti …
  • Saponia D.D.
    Saponia D.D. - Strategy, SWOT and Corporate Finance Report Summary Saponia D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Vivendi S.A.:企業の戦略・SWOT・財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • The Kiyo Bank Ltd:企業の戦略・SWOT・財務分析
    The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SLM Corp:企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hero AG:企業の戦略・SWOT・財務情報
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Sunstone Hotel Investors, Inc.:企業のM&A・事業提携・投資動向
    Sunstone Hotel Investors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sunstone Hotel Investors, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Landry’s Inc:企業の戦略・SWOT・財務情報
    Landry's Inc - Strategy, SWOT and Corporate Finance Report Summary Landry's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Bank of Maharashtra:企業の戦略・SWOT・財務情報
    Bank of Maharashtra - Strategy, SWOT and Corporate Finance Report Summary Bank of Maharashtra - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • A.H.A International Co., Ltd.:企業の戦略・SWOT・財務情報
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆